Trade UPB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Upstream Bio, Inc. (UPB) is trading at US$5.47, up 1.96% today as of Sep 22, 11:32 EDT. The company has a market capitalisation of US$381.75M. Over the past 52 weeks, UPB has traded between US$5.21 and US$33.68. On Syfe you can trade UPB with $0 commission and add it to your watchlist.
| Previous close | US$5.37 |
|---|---|
| Market cap | US$381.75M |
| 52-week range | US$5.21 – US$33.68 |
| Volume | 364.03K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Upstream Bio, Inc.
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.
Year: 2024
JPMorgan Downgrades Upstream Bio to Neutral From Overweight, Cuts Price Target to $8 From $35
Jun 12, 11:24 AM · MT Newswires
HC Wainwright Initiates Upstream Bio at Buy With $36 Price Target
Jun 3, 10:30 AM · MT Newswires
Mizuho Adjusts Price Target on Upstream Bio to $50 From $51, Maintains Outperform Rating
May 14, 10:20 AM · MT Newswires
Upstream Bio, Inc. (UPB) stock is trading at US$5.47, +1.96% from the previous close of US$5.37.
The market cap for Upstream Bio, Inc. (UPB) stock is approximately US$381.75M.
The 52-week high for Upstream Bio, Inc. (UPB) stock is US$33.68.
The 52-week low for Upstream Bio, Inc. (UPB) stock is US$5.21.
Upstream Bio, Inc. (UPB) does not currently pay a dividend.
Stay on top of UPB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
